Abstract
Treatment of vasovagal syncope usually demands no more than explanation and reassurance. However, if symptoms are frequent, severe and distressing and have not responded to the initial conservative measures, the physician’s thoughts naturally turn to drugs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Sander-Jensen K, Secher NH, Astrup A et al (1986) Hypotension induced by passive head-up tilt: endocrine and circulatory mechanisms. Am J Physiol 251:R743–749
Fitzpatrick A, Williams T, Ahmed R et al (1992) Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Card Pacing Electrophysiol 2:121–128
Klingenheben T, Kalusche D, Li Y-G et al (1996) Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardio-genic syncope: correlation with successful therapy with ß-receptor antagonist. J Cardiovasc Electrophysiol 7:802–808
Fitzpatrick AP, Ahmed R, Williams S, Sutton R (1991) A randomised trial of medical therapy in ‘malignant vasovagal or neurally mediated bradycardia/hypotension syndrome’. Eur J Card Pacing Electrophysiol 1:99–102
Brignole M, Menozzi C, Gianfranchi L et al (1992) A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 70:339–342
Mahanonda N, Bhuripanyo K, Kangkagate C et al (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table results. Am Heart J 130:1250–1253
Sutton R, Brignole M, Menozzi C et al (2000) Dual chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope. Pacemaker versus no therapy: a multicenter randomized study. Circulation 102:294–299
Scott W A, Giacomo P, Bromberg BI et al (1995) Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 76:400–402
Kurbaan AS, Wijesekera N, Franzen A-C et al (2001) Age related differences in underlying pathophysiology of suspected vasovagal syncope. J Am Coll Cardiol 37:146A(abstr)
Madrid AH, Ortega J, Rebollo RG et al (2001) Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective double blind, randomised and placebo controlled study. J Am Coll Cardiol 37:554–559
Morillo C, Leitch J, Yee R, Klein GJ (1993) A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 22:1843–1848
Milstein S, Buetikofer J, Donnigan A et al (1990) Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 65:1339–1344
Fitzpatrick A, Banner N, Cheng A et al (1993) Vasovagal reactions may occur after orthotopic heart transplantation. J Am Coll Cardiol 21:1132–1137
Dickinson CJ (1993) Fainting precipitated by collapse firing of venous baroreceptors. Lancet 342:970–972
Lee TM, Su SF, Chen MF et al (1996) Usefulness of transdermal scopolamine for vasovagal syncope. Am J Cardiol 78:480–482
Moya A, Permanyer-Miraldo G, Sagrista-Savleda J et al (1995) Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 25:65–69
Raviele A, Brignole M, Sutton R et al, for the Vasovagal Syncope International Study Investigators (1999) Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. A double-blind, randomised placebo-controlled trial. Circulation 99:1452–1457
Ward CR, Gray JC, Gilroy JJ, Kenny RA (1998) Midodrine: a role in the management of neurocardiogenic syncope. Heart 79:45–49
Natale A, Beheiry S, Tomassoni GF et al (1999) Randomized placebo control assessment of midodrine in the treatment of neurocardiogenic syncope. J Am Coll Cardiol 33:269A (abstr)
Zeng C, Zhu Z, Liu G et al (1998) Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally-mediated syncope. Am Heart J 136:852–858
Di Girolamo E, Di Forio C, Sabatini P et al (1999) Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomised, double-blind, placebo-controlled study. J Am Coll Cardiol 33:1227–1230
Petersen M, Williams TR, Gordon C et al (2000) The normal response to prolonged passive head-up tilt testing. Heart 84:509–514
Connolly SJ, Sheldon RS, Roberts RS, Gent M (1999) The North American Vasovagal Pacemaker Study. A randomised trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 33:16–20
Sheldon R, Rose S (2001) Components of clinical trials for vasovagal syncope. Europace 3:233–240
Malik P, Koshman ML, Sheldon R, Malik P (1997) Timing of first syncope recurrence predicts syncope frequency following a positive tilt table test. J Am Coll Cardiol 29:1284–1289
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer-Verlag Italia
About this paper
Cite this paper
Sutton, R. (2002). Therapy of Vasovagal Syncope: Is There a Role for Drugs Today?. In: Raviele, A. (eds) Cardiac Arrhythmias 2001. Springer, Milano. https://doi.org/10.1007/978-88-470-2103-7_12
Download citation
DOI: https://doi.org/10.1007/978-88-470-2103-7_12
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-2165-5
Online ISBN: 978-88-470-2103-7
eBook Packages: Springer Book Archive